Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients

A study of the relation between insulin resistance, insulin-like growth factor-1, and malignancy in type 2 diabetic patients

Menoufia Medical Journal ◽

10.4103/1110-2098.163908 ◽

2015 ◽

Vol 28 (2) ◽

pp. 494

Author(s):

DoaaS Elgendy ◽

NabilA El Kafrawy ◽

AliZ Glal ◽

MonaA Kandil ◽

AlaaA Eldin Dawood ◽

...

Keyword(s):

Insulin Resistance ◽

Growth Factor ◽

Diabetic Patients ◽

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden

Scandinavian Journal of Clinical and Laboratory Investigation ◽

10.1080/00365519850186544 ◽

1998 ◽

Vol 58 (4) ◽

pp. 353-360 ◽

Cited By ~ 51

Author(s):

P G Clauson ◽

K Brismar ◽

K Hall ◽

R Linnarsson ◽

V Grill

Keyword(s):

Growth Factor ◽

Binding Protein ◽

Diabetic Patients ◽

Factor Binding ◽

Factor I ◽

Growth Factor I ◽

Electrophysiological Abnormalities in Type 2 Diabetic Patients with Reduced Levels of Insulin-like Growth Factor I

Journal of International Medical Research ◽

10.1177/147323000603400103 ◽

2006 ◽

Vol 34 (1) ◽

pp. 21-29 ◽

Cited By ~ 1

Author(s):

R Godínez-Gómez ◽

B Trujillo-Hernández ◽

CE Tene ◽

M Huerta ◽

X Trujillo ◽

...

Keyword(s):

Growth Factor ◽

Diabetic Patients ◽

Factor I ◽

Growth Factor I ◽

Adipocyte precursor cells from first degree relatives of type 2 diabetic patients feature changes in hsa‐mir‐23a‐5p , ‐193a‐5p , and ‐193b‐5p and insulin‐like growth factor 2 expression

The FASEB Journal ◽

10.1096/fj.202002156rrr ◽

2021 ◽

Vol 35 (4) ◽

Author(s):

Paola Mirra ◽

Antonella Desiderio ◽

Rosa Spinelli ◽

Cecilia Nigro ◽

Michele Longo ◽

...

Keyword(s):

Growth Factor ◽

Precursor Cells ◽

Diabetic Patients ◽

First Degree Relatives ◽

Type 2 Diabetic ◽

Adipocyte Precursor

The effect of different antihypertensive treatment protocoles on glycemic control and lipid profile in type 2 diabetic patients with microalbuminuria and stage 1 hypertension

Endocrine Abstracts ◽

10.1530/endoabs.49.ep533 ◽

2017 ◽

Author(s):

Muge Erek ◽

Alparslan Ersoy ◽

Canan Ersoy

Keyword(s):

Glycemic Control ◽

Lipid Profile ◽

Antihypertensive Treatment ◽

Diabetic Patients ◽

Stage 1 ◽

Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data from single center

Endocrine Abstracts ◽

10.1530/endoabs.56.p491 ◽

2018 ◽

Author(s):

Soner Cander ◽

Murat Calapkulu ◽

Ozen Oz Gul ◽

Canan Ersoy

Keyword(s):

Glycemic Control ◽

Clinical Experience ◽

Diabetic Patients ◽

Single Center ◽

Is there a relation between statin use and glycemic control in type 2 diabetic patients?

Türkiye Aile Hekimliği Dergisi ◽

10.15511/tahd.15.02179 ◽

2015 ◽

Vol 19 (4) ◽

pp. 179-186

Author(s):

Altuğ Kut ◽

Yusuf Boşkuş ◽

Özgür Çaycı ◽

Ali Ümit Geçkil

Keyword(s):

Glycemic Control ◽

Diabetic Patients ◽

Type 2 Diabetic ◽

Statin Use

Self-care behaviors and glycemic control among type 2 diabetic patients in Freetown

10.26226/morressier.59d5184ed462b80296ca2b91 ◽

2017 ◽

Author(s):

Ghazzawi Manal

Keyword(s):

Glycemic Control ◽

Self Care ◽

Diabetic Patients ◽

Impact of Glycemic Control on Depression among Type 2 Diabetic Patients

International Journal of Medical Research Professionals ◽

10.21276/ijmrp.2016.2.6.015 ◽

2016 ◽

Vol 2 (6) ◽

Author(s):

Abrar Abdulaziz Alharbi ◽

Abrar Omar Eid ◽

Amani Ambarak Aldgail ◽

Asmaa Ali Sayis ◽

Doaa Mohammed Barnawi ◽

...

Keyword(s):

Glycemic Control ◽

Diabetic Patients ◽

OP7 EFFICACY, SAFETY, AND TOLERABILITY OF IPRAGLIFLOZIN IN ASIAN TYPE 2 DIABETIC PATIENTS WITH INADEQUATE GLYCEMIC CONTROL WITH METFORMIN. RESULTS OF A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER TRIAL

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(14)70213-x ◽

2014 ◽

Vol 106 ◽

pp. S4 ◽

Cited By ~ 1

Author(s):

L.-M. Chuang ◽

K.W. Min ◽

C.-H. Lu ◽

S. Kokubo ◽

S. Yoshida ◽

...

Keyword(s):

Glycemic Control ◽

Multicenter Trial ◽

Diabetic Patients ◽

Phase 3 ◽

Double Blind ◽

Type 2 Diabetic ◽

Inadequate Glycemic Control